Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates

Precision BioSciences (DTIL) came out with a quarterly loss of $2.83 per share versus the Zacks Consensus Estimate of a loss of$ 0.79. This compares to loss of $3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -258.23%. A quarter ago, it was expected that this genome editing company would post a loss of$ 0.77 per share when it actually produced earnings of $3.46, delivering a surprise of 549.35%.Over the last four quarters, t ...